Content deleted Content added
m Open access bot: doi added to citation with #oabot. |
Citation bot (talk | contribs) Add: s2cid, author pars. 1-1. Removed parameters. Some additions/deletions were actually parameter name changes. | You can use this bot yourself. Report bugs here. | Suggested by Abductive | Category:Genes on human chromosome 10 | via #UCB_Category 444/491 |
||
Line 101:
=== Dubin–Johnson syndrome ===
Several different mutations in this gene have been observed in patients with [[Dubin–Johnson syndrome]] (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia.<ref name="entrez"/><ref>{{Cite journal|
=== Iatrogenic Fanconi syndrome ===
Line 126:
<ref name="pmid12606735">{{cite journal |vauthors=Marcellin P, Chang TT, Lim SG, etal |title=Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B |journal=N. Engl. J. Med. |volume=348 |issue=9 |pages=808–16 |date=February 2003 |pmid=12606735 |doi=10.1056/NEJMoa020681 |url=https://scholarscompass.vcu.edu/intmed_pubs/45 }}</ref>
<ref name="pmid17172311">{{cite journal |vauthors=Weiss J, Theile D, Ketabi-Kiyanvash N, Lindenmaier H, Haefeli WE | title = Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors | journal = [[Drug Metab. Dispos.]] | volume = 35 | issue = 3 | pages = 340–4 |date=March 2007 | doi = 10.1124/dmd.106.012765 | pmid = 17172311 | s2cid = 46141353 | issn = }}</ref>
<ref name = "pmid19334329">{{cite journal |vauthors=Atta MG, Fine DM | title = Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice | journal = AIDS Read | volume = 19 | issue = 3 | pages = 118–9 |date=March 2009 | pmid = 19334329 | doi = | url = | issn = }}</ref>
Line 153:
| pmid = 15167283
| doi = 10.1097/00126334-200406010-00001
| s2cid = 6030800
| issn =
}}</ref>
Line 187 ⟶ 188:
{{refbegin | 2}}
*{{cite journal |vauthors=Keppler D, König J |title=Hepatic secretion of conjugated drugs and endogenous substances. |journal=Semin. Liver Dis. |volume=20 |issue= 3 |pages= 265–72 |year= 2001 |pmid= 11076395 |doi=10.1055/s-2000-9391 }}
*{{cite journal |vauthors=Gerk PM, Vore M |title=Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. |journal=J. Pharmacol. Exp. Ther. |volume=302 |issue= 2 |pages= 407–15 |year= 2002 |pmid= 12130697 |doi= 10.1124/jpet.102.035014 |s2cid=873234 }}
*{{cite journal |vauthors=Mayer R, Kartenbeck J, Büchler M, etal |title=Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. |journal=J. Cell Biol. |volume=131 |issue= 1 |pages= 137–50 |year= 1995 |pmid= 7559771 |doi=10.1083/jcb.131.1.137 | pmc=2120605 }}
*{{cite journal |vauthors=Büchler M, König J, Brom M, etal |title=cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. |journal=J. Biol. Chem. |volume=271 |issue= 25 |pages= 15091–8 |year= 1996 |pmid= 8662992 |doi=10.1074/jbc.271.25.15091 |doi-access=free }}
*{{cite journal |vauthors=Paulusma CC, Kool M, Bosma PJ, etal |title=A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. |journal=Hepatology |volume=25 |issue= 6 |pages= 1539–42 |year= 1997 |pmid= 9185779 |doi= 10.1002/hep.510250635 |s2cid=22635775 |url=https://pure.uva.nl/ws/files/3040383/3291_30375y.pdf }}
*{{cite journal |vauthors=Wada M, Toh S, Taniguchi K, etal |title=Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. |journal=Hum. Mol. Genet. |volume=7 |issue= 2 |pages= 203–7 |year= 1998 |pmid= 9425227 |doi=10.1093/hmg/7.2.203 |doi-access=free }}
*{{cite journal |vauthors=Evers R, Kool M, van Deemter L, etal |title=Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. |journal=J. Clin. Invest. |volume=101 |issue= 7 |pages= 1310–9 |year= 1998 |pmid= 9525973 |doi=10.1172/JCI119886 | pmc=508708 }}
Line 198 ⟶ 199:
*{{cite journal |vauthors=Tsujii H, König J, Rost D, etal |title=Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. |journal=Gastroenterology |volume=117 |issue= 3 |pages= 653–60 |year= 1999 |pmid= 10464142 |doi=10.1016/S0016-5085(99)70459-2 }}
*{{cite journal |vauthors=Kocher O, Comella N, Gilchrist A, etal |title=PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. |journal=Lab. Invest. |volume=79 |issue= 9 |pages= 1161–70 |year= 1999 |pmid= 10496535 |doi= }}
*{{cite journal |vauthors=Tanaka T, Uchiumi T, Hinoshita E, etal |title=The human multidrug resistance protein 2 gene: functional characterization of the 5'-flanking region and expression in hepatic cells. |journal=Hepatology |volume=30 |issue= 6 |pages= 1507–12 |year= 1999 |pmid= 10573531 |doi= 10.1002/hep.510300617 |s2cid=22514353 }}
*{{cite journal |vauthors=St-Pierre MV, Serrano MA, Macias RI, etal |title=Expression of members of the multidrug resistance protein family in human term placenta. |journal=Am. J. Physiol. Regul. Integr. Comp. Physiol. |volume=279 |issue= 4 |pages= R1495–503 |year= 2000 |pmid= 11004020 |doi= 10.1152/ajpregu.2000.279.4.R1495}}
*{{cite journal |vauthors=Keitel V, Kartenbeck J, Nies AT, etal |title=Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. |journal=Hepatology |volume=32 |issue= 6 |pages= 1317–28 |year= 2001 |pmid= 11093739 |doi= 10.1053/jhep.2000.19791 |s2cid=20920288 }}
*{{cite journal |vauthors=Ito S, Ieiri I, Tanabe M, etal |title=Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. |journal=Pharmacogenetics |volume=11 |issue= 2 |pages= 175–84 |year= 2001 |pmid= 11266082 |doi=10.1097/00008571-200103000-00008 }}
*{{cite journal |vauthors=Mor-Cohen R, Zivelin A, Rosenberg N, etal |title=Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. |journal=J. Biol. Chem. |volume=276 |issue= 40 |pages= 36923–30 |year= 2001 |pmid= 11477083 |doi= 10.1074/jbc.M105047200 |doi-access= free }}
Line 212 ⟶ 213:
| pmid = 16393861
| doi = 10.1080/00498250500354493
| s2cid = 6888528
| issn =
}}
| |||